Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00580203 · ClinicalTrials.gov registry record
Collection Of Tissue, Blood, and Other Specimens From Patients With Head and Neck Tumors To Study the Causes, Diagnosis, Prevention and Treatment of Cancers
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 1,468
- Enrollment target
NCT00580203: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00580203 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 1,468 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00580203 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 1,468 participants
- Enrollment target
Study Summary
This is a protocol to collect tissues, blood, and other specimens from patients with malignant or nonmalignant diseases of the head and neck. Collected specimens will be used in laboratory studies to investigate the growth, development, and transformation of normal and abnormal cells in the future.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,468 participants |
| Start Date | 2004-02 |
| Est. Completion | 2024-11-12 |
What the finished NCT00580203 record still lists
NCT00580203 is an observational study that tracks outcomes without assigning an intervention. Its 1,468 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00580203 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00580203 about?
NCT00580203 is a clinical study titled "Collection Of Tissue, Blood, and Other Specimens From Patients With Head and Neck Tumors To Study the Causes, Diagnosis, Prevention and Treatment of Cancers". This is a protocol to collect tissues, blood, and other specimens from patients with malignant or nonmalignant diseases of the head and neck. Collected specimens will be used in laboratory studies to investigate the growth, development, and transformation of normal and abnormal cells in the future.
What is the current status of trial NCT00580203?
This trial is currently completed. The enrollment target is 1,468 participants. The study started on 2004-02. Estimated completion is 2024-11-12.
Who is sponsoring clinical trial NCT00580203?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03936361 · 1,456 participants · Phase 3
Statins In Intracerbral Hemorrhage
- NCT06782347 · 1,454 participants · NA
Activating SilverSneakers Benefits for Seniors With Osteoarthritis
- NCT05869552 · 1,485 participants · NA
Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care
- NCT04566328 · 1,450 participants · Phase 3
Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia